Endoglin as a predictive biomarker for pemetrexed sensitivity in non-small-cell lung cancer: a cellular study. - Cheng CY; Chuang WC; Lin CP; Li CH; Chang HY; Wu WJ; Wu MF; Ko JL (Cancer chemotherapy and pharmacology, 2025)